PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Guangxi Health Commission Key Laboratory of Tumor Immunology and Receptor-Targeted Drug Basic Research, Guilin Medical University, Guilin, China.\', \'Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Guilin, China.\', \'Department of Radiotherapy III, Clinical Oncology Canter, The People\'s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.\', \'Breast Center, the Second Affiliated Hospital of Guilin Medical University, Guilin, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fendo.2022.829879
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 35399920
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35399920>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35399920>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all